详情
Manufacturer
Reliance Life Sciences Pvt. Ltd (Plant 6)(INDIA)
Registraction Number
MAL24086018AZ
Content:
- Active Ingredient: Bortezomib 3.5 mg (as a mannitol boronic ester).
- Excipients: The powder is lyophilized (freeze-dried) and needs to be reconstituted with sterile water for injection or sodium chloride solution1.
Indications:
- Multiple Myeloma: Bortezomib is indicated for the treatment of patients with multiple myeloma.
- Mantle Cell Lymphoma: It is also indicated for the treatment of patients with mantle cell lymphoma.
Instructions:
- Reconstitution:
- For intravenous use: Add 1.4 ml of sterile 0.9% sodium chloride solution to the vial containing Bortezomib powder. The solution should be clear and colorless.
- For subcutaneous use: Add 1.4 ml of sterile 0.9% sodium chloride solution to the vial. The final concentration will be 2.5 mg/ml.
更多 Complete Wellness 相关资料